Character Group (CCT)
London Exchange · UK · prices in GBX · close of 23 Oct 2026
Key indicators
| Last close | GBX 300.00 |
|---|---|
| 52-week range | 220.00 – 330.00 |
| Return, 1 month / 3 months | −2.9% / −1.3% |
| Return, 1 year / 3 years | +12.0% / +30.8% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 25 |
| Volatility (1 year) | 23.9% |
| Worst drawdown (1 year) | -18.6% |
| Average daily value traded | 4.84M GBX |
| Dividend yield | 2.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Character Group designs, develops and distributes toys, games and giftware, working with licensed entertainment brands as well as its own ranges. Its products reach customers through retailers and distributors, and the business is based in the United Kingdom. The company handles the design and sourcing of playthings and related consumer products, serving families and children through the toy trade, and it also manages licensing arrangements that let it make and market goods tied to popular characters and properties.
Character Group trades under the code CCT on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Character Group (CCT) trades on the London Exchange in UK. It last closed at GBX 300.00 on 23 October 2026.
Its price-based Market X-Ray is 70 out of 100 (a strong price profile), ranking 529 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 12.0% and over the last three months it fell 1.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 81 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 9.5% | ||
| From 52-week high | -6.5% | ||
| Momentum | 66 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -1.3% | ||
| 6-month return | 23.6% | ||
| 12-month return, skipping the last month | 15.3% | ||
| Stability (higher is calmer) | 77 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 23.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.6% | ||
| Liquidity | 68 · Fair | Moderate trading activity. | |
| Average daily value traded | 4.84M GBX | ||
| Zero-volume days | 1.7% | ||
| Income | 40 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.3% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −3.2% |
|---|---|
| 1 month | −2.9% |
| 3 months | −1.3% |
| 6 months | +23.6% |
| 1 year | +12.0% |
| 3 years | +30.8% |
| 5 years | −28.6% |
Signals
| 50-day / 200-day average | 313.56 / 273.95 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 8.76 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 16 Jul 2026 | GBP 0.0400 |
| 15 Jan 2026 | GBP 0.0300 |
| 10 Jul 2025 | GBP 0.0300 |
| 16 Jan 2025 | GBP 0.1100 |
| 11 Jul 2024 | GBP 0.0800 |
| 11 Jan 2024 | GBP 0.1100 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.